These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1275 related articles for article (PubMed ID: 26700992)

  • 21. Effect of implementation of guidelines on assessment and diagnosis of vertebral fractures in patients older than 50 years with a recent non-vertebral fracture.
    van der Velde RY; Bours SPG; Wyers CE; Lems WF; Geusens PPMM; van den Bergh JPW
    Osteoporos Int; 2017 Oct; 28(10):3017-3022. PubMed ID: 28748385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of fracture risk assessment tool score to bone mineral density for estimating fracture risk in patients with advanced prostate cancer on androgen deprivation therapy.
    James H; Aleksic I; Bienz MN; Pieczonka C; Iannotta P; Albala D; Mariados N; Mouraviev V; Saad F
    Urology; 2014 Jul; 84(1):164-8. PubMed ID: 24976229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A study of the value of trabecular bone score in fracture risk assessment of postmenopausal women.
    Mirzaei A; Jahed SA; Nojomi M; Rajaei A; Zabihiyeganeh M
    Taiwan J Obstet Gynecol; 2018 Jun; 57(3):389-393. PubMed ID: 29880171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FRAX® with or without BMD and TBS predicts fragility fractures in community-dwelling rural southern Indian postmenopausal women.
    Rajan R; Paul J; Cherian KE; Asha HS; Kapoor N; Paul TV
    Arch Osteoporos; 2020 Jun; 15(1):82. PubMed ID: 32483672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved fracture risk prediction by adding VFA-identified vertebral fracture data to BMD by DXA and clinical risk factors used in FRAX.
    Johansson L; Johansson H; Axelsson KF; Litsne H; Harvey NC; Liu E; Leslie WD; Vandenput L; McCloskey E; Kanis JA; Lorentzon M
    Osteoporos Int; 2022 Aug; 33(8):1725-1738. PubMed ID: 35451623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trabecular Bone Score (TBS) and TBS-Adjusted Fracture Risk Assessment Tool are Potential Supplementary Tools for the Discrimination of Morphometric Vertebral Fractures in Postmenopausal Women With Type 2 Diabetes.
    Choi YJ; Ock SY; Chung YS
    J Clin Densitom; 2016 Oct; 19(4):507-514. PubMed ID: 27130256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequency of FRAX risk factors in osteopenic postmenopausal women with and without history of fragility fracture.
    Baró F; Cano A; Sánchez Borrego R; Ferrer J; González Rodríguez SP; Neyro JL; Rodriguez Bueno E; Sancho C; Inaraja V; Fernández C; Corral C;
    Menopause; 2012 Nov; 19(11):1193-9. PubMed ID: 22948137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fracture Risk Indices From DXA-Based Finite Element Analysis Predict Incident Fractures Independently From FRAX: The Manitoba BMD Registry.
    Leslie WD; Luo Y; Yang S; Goertzen AL; Ahmed S; Delubac I; Lix LM
    J Clin Densitom; 2019; 22(3):338-345. PubMed ID: 30852033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased lower-extremity muscle performance is associated with decreased hip bone mineral density and increased estimated fracture risk in community-dwelling postmenopausal women.
    Dai D; Xu F; Sun R; Yuan L; Sheng Z; Xie Z
    Arch Osteoporos; 2020 Nov; 15(1):173. PubMed ID: 33141362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spine-Hip Discordance and FRAX assessment Fracture Risk in Postmenopausal Women with Osteopenia from Concordant Diagnosis Between Lumbar Spine and Femoral Neck.
    Goh TS; Kim E; Jeon YK; Hwangbo L; Kim IJ; Pak K; Kim SJ; Kim K
    J Clin Densitom; 2021; 24(4):548-556. PubMed ID: 33985893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establish and validate the reliability of predictive models in bone mineral density by deep learning as examination tool for women.
    Hung WC; Lin YL; Cheng TT; Chin WL; Tu LT; Chen CK; Yang CH; Wu CH
    Osteoporos Int; 2024 Jan; 35(1):129-141. PubMed ID: 37728768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcaneus ultrasonometry and dual-energy X-ray absorptiometry for the evaluation of vertebral fracture risk.
    Frediani B; Acciai C; Falsetti P; Baldi F; Filippou G; Siagkri C; Spreafico A; Galeazzi M; Marcolongo R
    Calcif Tissue Int; 2006 Oct; 79(4):223-9. PubMed ID: 16969597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative ultrasound and bone mineral density are equally strongly associated with risk factors for osteoporosis.
    Frost ML; Blake GM; Fogelman I
    J Bone Miner Res; 2001 Feb; 16(2):406-16. PubMed ID: 11204441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted vertebral fracture assessment for optimizing fracture prevention in Canada.
    Leslie WD; Lix LM; Binkley N
    Arch Osteoporos; 2020 May; 15(1):65. PubMed ID: 32363426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An optimal intervention threshold of FRAX in postmenopausal Thai women.
    Sribenjalak D; Charoensri S; Pongchaiyakul C
    Arch Osteoporos; 2022 Jan; 17(1):21. PubMed ID: 35072805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual energy X-ray absorptiometry of the calcaneus: comparison with other techniques to assess bone density and value in predicting risk of spine fracture.
    Yamada M; Ito M; Hayashi K; Ohki M; Nakamura T
    AJR Am J Roentgenol; 1994 Dec; 163(6):1435-40. PubMed ID: 7992742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is It Possible to Increase the Clinical Effectiveness of the Fracture Risk Assessment Tool in Osteopenia Patients by Taking Into Account Bone Mineral Density Values?
    Park JS; Lee J; Park YS
    J Clin Densitom; 2016; 19(3):340-5. PubMed ID: 26822485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Status of bone strength and factors associated with vertebral fracture in postmenopausal women with type 2 diabetes.
    Chen FP; Kuo SF; Lin YC; Fan CM; Chen JF
    Menopause; 2019 Feb; 26(2):182-188. PubMed ID: 30130285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [FRAX® thresholds to identify people with high or low risk of osteoporotic fracture in Spanish female population].
    Azagra R; Roca G; Martín-Sánchez JC; Casado E; Encabo G; Zwart M; Aguyé A; Díez-Pérez A;
    Med Clin (Barc); 2015 Jan; 144(1):1-8. PubMed ID: 24461732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The proportion of Thai postmenopausal women who would be eligible for anti-osteoporosis therapy.
    Chanidkul P; Sribenjalak D; Charoenngam N; Pongchaiyakul C
    PLoS One; 2023; 18(2):e0279829. PubMed ID: 36735672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 64.